v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2,514 $ 238,040,520 $ 45,789 $ (233,970,752) $ 4,118,071
Balance (in shares) at Dec. 31, 2024 2,514,499        
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 657 2,696,885     2,697,542
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 657,147        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (60,011)     (60,011)
Issuance of common stock to vendors $ 12 29,988     30,000
Issuance of common stock to vendors (in shares) 12,346        
Share-based compensation expense   63,599     63,599
Net loss       (2,951,268) (2,951,268)
Balance at Mar. 31, 2025 $ 3,183 240,770,981 45,789 (236,922,020) 3,897,933
Balance (in shares) at Mar. 31, 2025 3,183,992        
Balance at Dec. 31, 2025 $ 10,086 250,287,382 45,789 (245,051,132) $ 5,292,125
Balance (in shares) at Dec. 31, 2025 10,086,130       10,086,130
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 424 508,853     $ 509,277
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 423,799        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (17,742)     (17,742)
Issuance of common stock to vendors $ 8 9,994     $ 10,002
Issuance of common stock to vendors (in shares) 8,340       8,340
Share-based compensation expense   121,208     $ 121,208
Net loss       (2,824,965) (2,824,965)
Balance at Mar. 31, 2026 $ 10,518 $ 250,909,695 $ 45,789 $ (247,876,097) $ 3,089,905
Balance (in shares) at Mar. 31, 2026 10,518,269       10,518,269